Author: Anna Smith

Three men sentenced for supply of illicit meds

Three people have been handed custodial sentences in England for their involvement in the illegal supply of potentially dangerous prescription-only medicines.

Novartis’ crizanlizumab granted FDA Breakthrough Therapy

US regulators have granted Novartis’ crizanlizumab (SEG101) Breakthrough Therapy designation for the prevention of vaso-occlusive crises in patients with sickle cell disease.

Caritas Neuro Solutions & Innvocept team up

Scottish mental health and neurology research company Caritas Neuro Solutions has signed a landmark partnership deal with Mumbai, India-based group Innvocept Solutions.

Regeneron and Sanofi restructure immuno-oncology collaboration

Regeneron and Sanofi have restructured their global immuno-oncology discovery and development agreement for new immuno-oncology cancer treatments, with Sanofi set to pay $462 million to end the collaboration early.